These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6049616)

  • 1. Effect of monoamine oxidase inhibitors on the concentrations of dopamine and serotonin in the striatum of the cat with and without unilateral brainstem lesions.
    Singh P; Poirier LJ; Boucher R
    Can J Physiol Pharmacol; 1967 Sep; 45(5):897-904. PubMed ID: 6049616
    [No Abstract]   [Full Text] [Related]  

  • 2. Evidence for dopamine deamination by both type A and type B monoamine oxidase in rat brain in vivo and for the degree of inhibition of enzyme necessary for increased functional activity of dopamine and 5-hydroxytryptamine.
    Green AR; Mitchell BD; Tordoff AF; Youdim MB
    Br J Pharmacol; 1977 Jul; 60(3):343-9. PubMed ID: 890205
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of tranylcypromine upon 5-hydroxytryptaminergic neurons of rat brain stem.
    Bartonícek V
    Med Pharmacol Exp Int J Exp Med; 1966; 14(4):365-70. PubMed ID: 5952329
    [No Abstract]   [Full Text] [Related]  

  • 4. Brain amine concentrations after monoamine oxidase inhibitor administration.
    Jones AB; Pare CM; Nicholson WJ; Price K; Stacey RS
    Br Med J; 1972 Jan; 1(5791):17-9. PubMed ID: 5008339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of perturbation of cerebral amine metabolism on operationally defined learning and memory processes of goldfish.
    Stahl SM; Narotzky RA; Boshes B; Zeller EA
    Biol Psychiatry; 1974 Dec; 9(3):295-323. PubMed ID: 4441577
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of dihydroxyphenylalanine on the serotonin content of rat brain following pretreatment with monoamine oxidase inhibitors].
    Popov N; Matthies H
    Acta Biol Med Ger; 1966; 17(5):637-43. PubMed ID: 5991588
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of monoamine oxidase inhibitors on the content of catecholamines in different parts of the brain in cats].
    Vysotskaia NB; Kaverina NV; Mirzoian RS; Rozonov IuB
    Farmakol Toksikol; 1967; 30(3):289-92. PubMed ID: 5597732
    [No Abstract]   [Full Text] [Related]  

  • 8. Differential effects of monoamine oxidase inhibitors.
    Maickel RP; Rompalo AM; Cox RH
    Res Commun Chem Pathol Pharmacol; 1974 Aug; 8(4):727-30. PubMed ID: 4420181
    [No Abstract]   [Full Text] [Related]  

  • 9. Responses of developing rats to L-tryptophan plus an MAOI-I. Monitoring changes in behaviour, brain 5-HT and tryptophan.
    Atterwill CK; Green AR
    Neuropharmacology; 1980 Apr; 19(4):325-35. PubMed ID: 7383278
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of diphenylhydantoin on brain 5-hydroxytryptamine metabolism and function.
    Green AR; Grahame-Smith DG
    Neuropharmacology; 1975 Feb; 14(2):107-13. PubMed ID: 1153078
    [No Abstract]   [Full Text] [Related]  

  • 11. The influence of increased brain 5-hydroxytryptamine upon the respiratory activity of cats.
    Armijo JA; Flórez J
    Neuropharmacology; 1974 Nov; 13(10-11):977-86. PubMed ID: 4548170
    [No Abstract]   [Full Text] [Related]  

  • 12. Relationship between the pharmacological and biochemical properties of a monoamine oxidase inhibitor preferentially affecting 5-hydroxytryptamine oxidation.
    Christmas AJ; Hall DW; Hayward A; Maxwell DR
    Br J Pharmacol; 1970 May; 39(1):207P-208P. PubMed ID: 5420104
    [No Abstract]   [Full Text] [Related]  

  • 13. [Various effects of monoamine oxidase inhibitors under conditions of complete monoamine oxidase inhibition on the serotonin, dopamine and noradrenaline levels in the rat brain].
    Matthies H; Popov N
    Acta Biol Med Ger; 1966; 17(4):488-97. PubMed ID: 5983631
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of brain norepinephrine in the anorexic effects of dextroamphetamine and monoamine oxidase inhibitors in the rat.
    Holtzman SG; Jewett RE
    Psychopharmacologia; 1971; 22(2):151-61. PubMed ID: 5124188
    [No Abstract]   [Full Text] [Related]  

  • 15. Assessment of MAO inhibitors using postmortem human brain tissue: biochemical and therapeutic implications.
    Reynolds GP; Riederer P
    Mod Probl Pharmacopsychiatry; 1983; 19():255-9. PubMed ID: 6408410
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies in vivo on the relationship between brain tryptophan, brain 5-HT synthesis and hyperactivity in rats treated with a monoamine oxidase inhibitor and L-tryptophan.
    Grahame-Smith DG
    J Neurochem; 1971 Jun; 18(6):1053-66. PubMed ID: 4254940
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of tranylcypromine on glycogenolysis in the rat brain].
    Rinaudo MT; Curto M; Bruno R; Torre E; Bogetto F; Torre M
    Boll Soc Ital Biol Sper; 1979 Jan; 55(2):148-52. PubMed ID: 17955640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The action of neuroleptics in rats with altered catecholamine metabolism. 3. The effect of chlorpromazine, haloperidol and thioridazine on the brain dopamine and serotonin contents in the rats pretreated with MAO inhibitors.
    Vetulani J
    Pol J Pharmacol Pharm; 1973; 25(1):65-83. PubMed ID: 4775865
    [No Abstract]   [Full Text] [Related]  

  • 19. Influence of drugs on the firing of serotonin-containing neurons in brain.
    Aghajanian GK
    Fed Proc; 1972; 31(1):91-6. PubMed ID: 4333252
    [No Abstract]   [Full Text] [Related]  

  • 20. Antihypertensive and monoamine oxidase inhibitory activity of 3-amino-2-oxazolidinone (3AO) and its condensation product with 2-substituted-3-formyl-4-oxo-(4H) pyrido(1,2-a)pyrimidines.
    Kaul CL; Grewal RS
    Biochem Pharmacol; 1972 Feb; 21(3):303-16. PubMed ID: 5014489
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.